Atrial fibrillation, the dangerous heart rhythm disorder commonly referred to as A-fib, affects more than 10 million U.S. adults. Even with so many people affected, doctors have been stuck with the ...

After a record year in 2024, where companies raised ₹1.36 lakh crore through the QIP route, the figure has seen a dip this ...

But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study. And through the first nine months of 2025, Zepbound generated $9.3 billion ...

Biohaven shares fell 16.19% in after-hours trading Wednesday after its Phase 2 depression drug trial missed the primary ...

Retirement accounts clawed back much of what was lost while highlighting how deeply policy shifts can hit workers’ savings.

How a reclusive former auditor turned $5,000 into $22 million without using options, "moonshot" investments, or leverage of any kind.

Agios upgraded after FDA approval of Aqvesme for thalassemia. Explore AGIO’s financial outlook, upside potential, and future ...

A new study reveals that 86% of high-risk retirees fail to diversify their portfolios properly. Here’s how to fix this issue and protect your retirement.

What is the best time of year to take required minimum distributions from a traditional IRA? A recent study has some ...

William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage ...

CG Oncology leads in NMIBC treatment with creto, strong efficacy data, and $2B+ revenue potential. Learn more about CGON ...

The American Cancer Society projected for 2025 that there would be over 154,000 new cases of colorectal cancer and 52,900 deaths.